Mechanisms that regulate stem cell aging and life span - PubMed (original) (raw)
Review
Mechanisms that regulate stem cell aging and life span
Robert A J Signer et al. Cell Stem Cell. 2013.
Abstract
Mammalian aging is associated with reduced tissue regeneration, increased degenerative disease, and cancer. Because stem cells regenerate many adult tissues and contribute to the development of cancer by accumulating mutations, age-related changes in stem cells likely contribute to age-related morbidity. Consistent with this, stem cell function declines with age in numerous tissues as a result of gate-keeping tumor suppressor expression, DNA damage, changes in cellular physiology, and environmental changes in tissues. It remains unknown whether declines in stem cell function during aging influence organismal longevity. However, mechanisms that influence longevity also modulate age-related morbidity, partly through effects on stem cells.
Copyright © 2013 Elsevier Inc. All rights reserved.
Figures
Figure 1. Multiple Sources of Damage to Biological Macromolecules Reduce Stem Cell Function during Aging
Sources of damage (top row) including ROS, exogenous mutagens, proliferation, infidelity of DNA replication, and errors in protein translation can damage macromolecules or organelles within a cell (middle row). Damage accumulates in DNA, proteins, mitochondria, and lipids during aging and contributes to declines in stem cell function, tissue regeneration, and life span. The cellular consequences of this damage (bottom row) include cell death, cellular senescence, differentiation, altered cellular physiology, and cancer. All of these mechanisms are interrelated; damage to one component, such as telomeres, can influence the function of other components, such as mitochondria (Sahin and Depinho, 2010).
Figure 2. Heterochronic Genes Regulate Increases in the Expression of GateKeeping Tumor Suppressors and Declines in Aging Stem Cell Function
Stem cell self-renewal and stem cell aging are regulated by networks of proto-oncogenes (green) and tumor suppressors (red). (A) let-7 microRNA is an evolutionarily conserved heterochronic gene that regulates the timing of developmental events from C. elegans to mammals (Pasquinelli et al., 2000). let-7b expression increases with age in mammals, reducing the expression of the Hmga2 chromatin-associated factor, and increasing the expression of the JunB, p16Ink4a, and p19Arf tumor suppressors (Nishino et al., 2008). The increase in p16Ink4a expression during aging reduces stem cell function in multiple tissues (Janzen et al., 2006; Krishnamurthy et al., 2006; Molofsky et al., 2006). let-7 microRNA also increases with age in Drosophila, acting in the niche to non-cell-autonomously reduce spermatogonial stem cell function by impairing the secretion of Unpaired (Toledano et al., 2012). (B) p16Ink4a and p19Arf expression are also repressed in mammalian stem cells by polycomb proteins, including Bmi-1 and Ezh2 (Jacobs et al., 1999; Lessard and Sauvageau, 2003; Molofsky et al., 2003; Park et al., 2003; Chen et al., 2009b). In the absence of Bmi-1, p16Ink4a and p19Arf expression are induced in postnatal stem cells from multiple tissues, inducing cell death, cellular senescence, or premature differentiation. These pathways illustrate how networks of proto-oncogenes and tumor suppressors regulate stem cell maintenance and homeostasis in adult tissues. The way in which proto-oncogenic and tumor suppressor signals are balanced within these networks changes with age in stem cells.
Figure 3. The Multifaceted and Context-Dependent Effects of p53 in Stem Cells
The consequences of tumor suppressor expression in stem cells can be context dependent. p53 can have both positive (blue) and negative (red) effects on stem cell function, depending on context and expression level. When expressed at low levels, p53 can promote stem cell maintenance by promoting the maintenance of genomic integrity and by regulating metabolism. When expressed at high levels, p53 can promote stem cell depletion through cell death or cellular senescence. The aggregate effect of these functions influences longevity, cancer incidence, and tissue regeneration during aging (Tyner et al., 2002; TeKippe et al., 2003; van Heemst et al., 2005; Dumble et al., 2007; Schoppy et al., 2010; Gannon et al., 2011).
Figure 4. Many Components of the Insulin/PI3K Signaling Pathway Regulate Stem Cell Function and Aging
A variety of tyrosine kinase receptors, including the insulin receptor, activate the PI3K pathway, which leads to the activation of both mTORC1 and mTOCR2 (Laplante and Sabatini, 2012). mTORC2 can phosphorylate and activate Akt, SGK, and protein kinase C (PKC). Activated Akt can phosphorylate FoxO transcription factors, restricting their localization to the cytosol. FoxOs that translocate to the nucleus can transcriptionally activate the expression of a variety of genes, including protein folding chaperones, antioxidant enzymes, and metabolic regulators (Salih and Brunet, 2008). Activated Akt can also activate mTORC1 by phosphorylating TSC2, which relieves the inhibitory effects of the TSC1/TSC2 complex on Rheb. mTORC1 activates mechanisms that promote protein translation and lipid and nucleic acid synthesis and inhibit autophagy. The components of these pathways that have not yet been studied in stem cells are likely to regulate stem cell function and perhaps even stem cell aging.
Figure 5. Proteostasis Is Required for Cellular Homeostasis during Aging
Proteostasis is regulated by protein translation rates, which are controlled by ribosome biogenesis, recruitment, and loading. Chaperones promote folding of nascent polypeptides or re-folding of misfolded proteins to prevent protein aggregation. Misfolded or damaged proteins can be ubiquitylated and targeted for proteosomal degradation or engulfed and degraded by auto-phagosomes. Interventions that promote proteostasis can slow aging, reduce the incidence of age-related diseases, and increase life span (Cohen et al., 2009; Durieux et al., 2011; Taylor and Dillin, 2011). These mechanisms are likely to influence tissue regeneration and stem cell function during aging, but this remains largely unstudied.
Similar articles
- Metabolic regulation of stem cell function in tissue homeostasis and organismal ageing.
Chandel NS, Jasper H, Ho TT, Passegué E. Chandel NS, et al. Nat Cell Biol. 2016 Aug;18(8):823-32. doi: 10.1038/ncb3385. Epub 2016 Jul 18. Nat Cell Biol. 2016. PMID: 27428307 Review. - Stem Cell Aging in Lifespan and Disease: A State-of-the-Art Review.
Sameri S, Samadi P, Dehghan R, Salem E, Fayazi N, Amini R. Sameri S, et al. Curr Stem Cell Res Ther. 2020;15(4):362-378. doi: 10.2174/1574888X15666200213105155. Curr Stem Cell Res Ther. 2020. PMID: 32053079 Review. - Tumor suppressor dosage regulates stem cell dynamics during aging.
Gatza C, Moore L, Dumble M, Donehower LA. Gatza C, et al. Cell Cycle. 2007 Jan 1;6(1):52-5. doi: 10.4161/cc.6.1.3667. Epub 2007 Jan 4. Cell Cycle. 2007. PMID: 17245110 Review. - Stem Cell Aging and Sex: Are We Missing Something?
Dulken B, Brunet A. Dulken B, et al. Cell Stem Cell. 2015 Jun 4;16(6):588-90. doi: 10.1016/j.stem.2015.05.006. Cell Stem Cell. 2015. PMID: 26046758 Free PMC article. - Epigenetic regulation of aging stem cells.
Pollina EA, Brunet A. Pollina EA, et al. Oncogene. 2011 Jul 14;30(28):3105-26. doi: 10.1038/onc.2011.45. Epub 2011 Mar 28. Oncogene. 2011. PMID: 21441951 Review.
Cited by
- Exosomal misfolded proteins released by cancer stem cells: dual functions in balancing protein homeostasis and orchestrating tumor progression.
Bhattacharya A, Chatterji U. Bhattacharya A, et al. Discov Oncol. 2024 Aug 31;15(1):392. doi: 10.1007/s12672-024-01262-z. Discov Oncol. 2024. PMID: 39215782 Free PMC article. Review. - G2 arrest primes hematopoietic stem cells for megakaryopoiesis.
Garyn CM, Bover O, Murray JW, Ma J, Salas-Briceno K, Ross SR, Snoeck HW. Garyn CM, et al. Cell Rep. 2024 Jul 23;43(7):114388. doi: 10.1016/j.celrep.2024.114388. Epub 2024 Jun 26. Cell Rep. 2024. PMID: 38935497 Free PMC article. - DOS-3 mediates cell-non-autonomous DAF-16/FOXO activity in antagonizing age-related loss of C. elegans germline stem/progenitor cells.
Zhang Z, Yang H, Fang L, Zhao G, Xiang J, Zheng JC, Qin Z. Zhang Z, et al. Nat Commun. 2024 Jun 8;15(1):4904. doi: 10.1038/s41467-024-49318-6. Nat Commun. 2024. PMID: 38851828 Free PMC article. - Anti-ageing antibodies revive the immune system.
Kasu YAT, Signer RAJ. Kasu YAT, et al. Nature. 2024 Apr;628(8006):43-45. doi: 10.1038/d41586-024-00680-x. Nature. 2024. PMID: 38538888 No abstract available. - Regenerative loss in the animal kingdom as viewed from the mouse digit tip and heart.
Tan FH, Bronner ME. Tan FH, et al. Dev Biol. 2024 Mar;507:44-63. doi: 10.1016/j.ydbio.2023.12.008. Epub 2023 Dec 24. Dev Biol. 2024. PMID: 38145727 Review.
References
- Ahlqvist KJ, Hämaäläinen RH, Yatsuga S, Uutela M, Terzioglu M, Götz A, Forsström S, Salven P, Angers-Loustau A, Kopra OH, et al. Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice. Cell Metab. 2012;15:100–109. - PubMed
- Allsopp RC, Morin GB, DePinho R, Harley CB, Weissman IL. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood. 2003;102:517–520. - PubMed
- Ambros V, Horvitz HR. Heterochronic mutants of the nematode Caenorhabditis elegans. Science. 1984;226:409–416. - PubMed
- Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000;406:641–645. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical